| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Kenneth I Kaitin is Director at CRIS. Kenneth I Kaitin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8K at current prices.
The CRIS filings lean toward selling, a net 19,800 shares.
Kenneth I Kaitin has 17 Form 4 filings on record from January 2015 to July 2026, all as Director at Curis (CRIS), 2015–2026.
The 22 reported transactions were 12 option or other derivative awards, 4 option exercises, 3 open-market sales and 1 open-market purchase, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $5K and 2 sales worth about $42K.
The only open-market purchase was 10,000 shares of CRIS at an average $0.55 on March 31, 2026, about $5K.
The largest open-market sale was 15,000 shares of CRIS at an average $1.76 on May 26, 2016, about $26K.